CDH1 and cancer: Patients and families suggestive of HDGC with uninformative results (about 50–70% of cases), might have an undetectable defect in CDH1 gene (i.e., mosaicism, sequence variant in an intron or regulatory region, or others not covered for technical limits) or pathogenic variants in other cancer predisposition genes.